{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:15:52Z","timestamp":1790745352795,"version":"4.1.0"},"reference-count":47,"publisher":"BMJ","issue":"3","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"unspecified","delay-in-days":8,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Sant\u00e9 Publique France"},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-16-CONV-0005"],"award-info":[{"award-number":["ANR-16-CONV-0005"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003762","name":"Institut Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2023,7,28]]},"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>We aimed to describe patients with autoimmune diseases (AID) developing invasive fungal disease (IFD) and identify factors associated with short-term mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We analysed cases of IFD associated with AID from the surveillance network of invasive fungal diseases (R\u00e9seau de surveillance des infections fongiques invasives, RESSIF) registry of the French national reference centre for invasive mycoses. We studied association of AID-specific treatments with 30-day mortality. We analysed total lymphocyte and CD4-T cell counts in patients with\n                      <jats:italic>Pneumocystis jirovecii<\/jats:italic>\n                      pneumonia (PCP).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 2012 to 2018, 549 individuals with IFD and AID were included, mainly with PCP (n=227, 41.3%), fungemia (n=167, 30.4%) and invasive aspergillosis (n=84, 15.5%). Rheumatoid arthritis (RA) and anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitides (AAV) were the most frequent AID in PCP (n=55\u2009and 25, respectively) and invasive aspergillosis (n=15\u2009and 10, respectively), inflammatory bowel diseases (IBDs) were predominant in fungemia (n=36). At IFD diagnosis, 365 (66.5%) patients received glucocorticoids (GCs), 285 (51.9%) immunosuppressants, 42 (7.7%) tumor necrosis factor (TNF)-\u03b1 blockers, 75 (13.7%) other biologics. Mortality at 30 days was 28.1% (143\/508). Fungemia and high-dose GCs were independently associated with higher 30-day mortality. In PCP patients, lymphopenia &lt;1500\/mm\n                      <jats:sup>3<\/jats:sup>\n                      was frequent (132\/179, 73.7%) even if CD4+T\u2009cell count exceeded 200\/mm\n                      <jats:sup>3<\/jats:sup>\n                      in 56\/78 patients (71.8%) (median 472.5\/mm\n                      <jats:sup>3<\/jats:sup>\n                      , IQR 160\u2013858).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>IFD associated with AID occurs primarily in RA, AAV and IBD, especially when treated with GCs and immunosuppressants. Mortality is high, especially for patients on high-dose GCs. Lymphopenia may help identify risk of PCP, but normal CD4+T\u2009cell count does not rule out the risk. Further studies are needed to assess the individual risk factors for IFD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/rmdopen-2023-003281","type":"journal-article","created":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T06:10:26Z","timestamp":1694067026000},"page":"e003281","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":20,"title":["Invasive fungal diseases in patients with autoimmune diseases: a case series from the French RESSIF network"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-1744","authenticated-orcid":false,"given":"Simon","family":"Galmiche","sequence":"first","affiliation":[{"name":"Emerging Diseases Epidemiology Unit, Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, Paris, \u00cele-de-France, France"},{"name":"Ecole doctorale Pierre Louis de sant\u00e9 publique, Sorbonne Universit\u00e9, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Thoreau","sequence":"additional","affiliation":[{"name":"National Referral Center for Rare Systemic Autoimmune Diseases, Department of Internal Medicine, Cochin Hospital, AP\u2010HP, Universit\u00e9 Paris Cit\u00e9, Paris, \u00cele-de-France, France"},{"name":"INSERM U1016, Cochin Institute, Paris, Universit\u00e9 Paris Cit\u00e9, CNRS UMR 8104, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Bretagne","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, H\u00f4pital St Louis, APHP, Paris, \u00cele-de-France, France"},{"name":"Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, CNRS, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Alanio","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, H\u00f4pital St Louis, APHP, Paris, \u00cele-de-France, France"},{"name":"Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, CNRS, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Paugam","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, Universit\u00e9 Paris Cit\u00e9, Cochin Hospital, APHP, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Letscher-Bru","sequence":"additional","affiliation":[{"name":"Laboratoire de Parasitologie et Mycologie M\u00e9dicale, Les H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, France"},{"name":"Institut de Parasitologie et Pathologie Tropicale, UR7292 Dynamique des interactions h\u00f4te pathog\u00e8ne, F\u00e9d\u00e9ration de M\u00e9decine Translationnelle, Universit\u00e9 de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Cassaing","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, Universit\u00e9 de Toulouse, CHU Toulouse, Toulouse, Occitanie, France"},{"name":"PharmaDev, Facult\u00e9 de Pharmacie, Universit\u00e9 de Toulouse, UPS, IRD, Toulouse, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Gangneux","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Rennes, CHU, INSERM, Irset: Institut de Recherche en Sant\u00e9, Environnement et Travail, UMR_S 1085, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Guegan","sequence":"additional","affiliation":[{"name":"Universit\u00e9 de Rennes, CHU, INSERM, Irset: Institut de Recherche en Sant\u00e9, Environnement et Travail, UMR_S 1085, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Favennec","sequence":"additional","affiliation":[{"name":"French National Cryptosporidiosis Reference Center, CHU de Rouen, Rouen, Normandie, France"},{"name":"EA 7510, UFR Sant\u00e9, University of Rouen Normandy, Normandy University, Rouen, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alida","family":"Minoza","sequence":"additional","affiliation":[{"name":"Facult\u00e9 de M\u00e9decine et Pharmacie, Universit\u00e9 de Poitiers, Poitiers, Nouvelle-Aquitaine, France"},{"name":"D\u00e9partement des agents anti-infectieux, Service de Mycologie-Parasitologie, CHU Poitiers, Poitiers, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florent","family":"Morio","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, CHU Nantes, Nantes, Pays de la Loire, France"},{"name":"UR 1155 IICiMed, Institut de Recherche en Sant\u00e9 2, Universit\u00e9 de Nantes, Nantes, Pays de la Loire, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Bonhomme","sequence":"additional","affiliation":[{"name":"Microbiologie, CHU de Caen, ToxEMAC-ABTE Unicaen, Caen, Normandie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Desoubeaux","sequence":"additional","affiliation":[{"name":"Centre d\u2019\u00c9tude des Pathologies Respiratoires - Inserm UMR1100, Universit\u00e9 de Tours, Tours, France"},{"name":"Parasitologie - Mycologie - M\u00e9decine tropicale, CHU de Tours, Tours, Centre-Val de Loire, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odile","family":"Eloy","sequence":"additional","affiliation":[{"name":"Microbiologie, CH Versailles, Le Chesnay, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia","family":"Hasseine","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, h\u00f4pital de l'Archet, CHU Nice, Nice, Provence-Alpes-C\u00f4te d'Azur, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mil\u00e8ne","family":"Sasso","sequence":"additional","affiliation":[{"name":"Laboratoire de Parasitologie - Mycologie, CHU N\u00eemes, Universit\u00e9 de Montpellier, CNRS, IRD, MiVEGEC, Nimes, Occitanie, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Millon","sequence":"additional","affiliation":[{"name":"Laboratoire de Parasitologie - Mycologie, CHU de Besan\u00e7on, Besan\u00e7on, Bourgogne-Franche-Comt\u00e9, France"},{"name":"UMR 6249 CNRS Chrono-Environnement, Universit\u00e9 Bourgogne Franche-Comt\u00e9, Besan\u00e7on, Bourgogne - Franche-Comt\u00e9, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Pauline","family":"Bellanger","sequence":"additional","affiliation":[{"name":"Laboratoire de Parasitologie - Mycologie, CHU de Besan\u00e7on, Besan\u00e7on, Bourgogne-Franche-Comt\u00e9, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Poirier","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, CHU Clermont-Ferrand, Clermont-Ferrand, France"},{"name":"Microbes, Intestin, Inflammation et Susceptibilit\u00e9 de l'H\u00f4te (M2iSH), UMR Inserm\/Universit\u00e9 Clermont Auvergne U1071, USC INRA 2018, Clermont-Ferrand, Auvergne-Rh\u00f4ne-Alpes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxime","family":"Moniot","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, CHU Clermont-Ferrand, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taieb","family":"Chouaki","sequence":"additional","affiliation":[{"name":"Mycologie - parasitologie, CHU Amiens-Picardie, Amiens, Hauts-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Huguenin","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, h\u00f4pital Maison-Blanche, CHU de Reims, Reims, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Dalle","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, Plateforme de Biologie Hospitalo-Universitaire G\u00e9rard Mack, Dijon, Bourgogne-Franche-Comt\u00e9, France"},{"name":"UMR PAM Univ Bourgogne Franche-Comt\u00e9 - AgroSup Dijon - Equipe Vin, Aliment, Microbiologie, Stress, Universit\u00e9 Bourgogne Franche-Comt\u00e9, Dijon, Bourgogne-Franche-Comt\u00e9, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Bouteille","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, Centre de Biologie et de Recherche en Sant\u00e9, CHU Limoges, Limoges, Nouvelle-Aquitaine, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Nicolas","sequence":"additional","affiliation":[{"name":"Mycologie - Parasitologie, Centre Hospitalier Universitaire Pointe-\u00e0-Pitre Abymes, Pointe-\u00e0-Pitre, Guadeloupe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Desbois-Nogard","sequence":"additional","affiliation":[{"name":"Parasitologie - Mycologie, CHU de Martinique, Fort-de-France, Martinique"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Elisabeth","family":"Bougnoux","sequence":"additional","affiliation":[{"name":"Laboratoire de Parasitologie - Mycologie, Service de Microbiologie, Necker-Enfants Malades University Hospital, APHP, Paris, \u00cele-de-France, France"},{"name":"Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, Unit\u00e9 Biologie et Pathog\u00e9nicit\u00e9 Fongiques, D\u00e9partement Mycologie, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Danion","sequence":"additional","affiliation":[{"name":"Maladies infectieuses et tropicales, Les H\u00f4pitaux Universitaires de Strasbourg, Strasbourg, Grand Est, France"},{"name":"Laboratoire d'Immuno-rhumatologie mol\u00e9culaire UMR_S 1109, INSERM, Strasbourg, Grand Est, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Poindron","sequence":"additional","affiliation":[{"name":"Service d'Immunologie clinique, Hopitaux universitaires de Strasbourg, Strasbourg, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"N\u00e9el","sequence":"additional","affiliation":[{"name":"CRTI UMR 1064, INSERM, Universit\u00e9 de Nantes, Nantes, France"},{"name":"Service de M\u00e9decine interne, CHU Nantes, Nantes, Pays de la Loire, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Boukris-Sitbon","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, CNRS, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Lanternier","sequence":"additional","affiliation":[{"name":"Institut Pasteur, Universit\u00e9 Paris Cit\u00e9, CNRS, National Reference Center for Invasive Mycoses and Antifungals, Translational Mycology Research Group, Mycology Department, Paris, \u00cele-de-France, France"},{"name":"Infectious Diseases Unit, Necker-Enfants Malades University Hospital, AP-HP, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6612-7336","authenticated-orcid":false,"given":"Benjamin","family":"Terrier","sequence":"additional","affiliation":[{"name":"National Referral Center for Rare Systemic Autoimmune Diseases, Department of Internal Medicine, Cochin Hospital, AP\u2010HP, Universit\u00e9 Paris Cit\u00e9, Paris, \u00cele-de-France, France"},{"name":"Universit\u00e9 Paris Cit\u00e9, U970, PARCC, INSERM, Paris, \u00cele-de-France, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"2025090313403533000_9.3.e003281.1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.19927"},{"key":"2025090313403533000_9.3.e003281.2","first-page":"246","article-title":"Pneumocystis carinii pneumonia in the course of connective tissue disease: report of 34 cases","volume":"21","author":"Godeau","year":"1994","journal-title":"J Rheumatol"},{"key":"2025090313403533000_9.3.e003281.3","doi-asserted-by":"publisher","DOI":"10.3201\/eid2009.131668"},{"key":"2025090313403533000_9.3.e003281.4","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<780::AID-ANR23>3.0.CO;2-M"},{"key":"2025090313403533000_9.3.e003281.5","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew200"},{"key":"2025090313403533000_9.3.e003281.6","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-012-0796-5"},{"key":"2025090313403533000_9.3.e003281.7","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780401213"},{"key":"2025090313403533000_9.3.e003281.8","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/myc.12753","article-title":"Fungal infections in patients with inflammatory bowel disease: A systematic review","volume":"61","author":"Stamatiades","year":"2018","journal-title":"Mycoses"},{"key":"2025090313403533000_9.3.e003281.9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/acr.20435","article-title":"Pneumocystis Jiroveci pneumonia in giant cell arteritis: A case series","volume":"63","author":"Kermani","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025090313403533000_9.3.e003281.10","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.amjmed.2014.07.010","article-title":"Incidence of Pneumocystis Jiroveci pneumonia among groups at risk in HIV-negative patients","volume":"127","author":"Fillatre","year":"2014","journal-title":"Am J Med"},{"key":"2025090313403533000_9.3.e003281.11","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1007\/s10067-021-05660-4","article-title":"Pneumocystis Jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study","volume":"40","author":"Hsu","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2025090313403533000_9.3.e003281.12","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.medmal.2020.01.014","article-title":"Candida bloodstream infection in patients with systemic autoimmune diseases","volume":"50","author":"Vaquero-Herrero","year":"2020","journal-title":"Med Mal Infect"},{"key":"2025090313403533000_9.3.e003281.13","first-page":"269","article-title":"Infectious complications of TNF-\u0391 inhibitor monotherapy versus combination therapy with immunomodulators in inflammatory bowel disease: analysis of the food and Drug Administration adverse event reporting system","volume":"22","author":"Deepak","year":"2013","journal-title":"J Gastrointest Liver Dis JGLD"},{"key":"2025090313403533000_9.3.e003281.14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.revmed.2006.07.007","article-title":"Aspergillosis in systemic diseases treated with steroids and\/or immunosuppressive drugs: report of 9 cases and review of the literature","volume":"27","author":"Stankovic","year":"2006","journal-title":"Rev Med Interne"},{"key":"2025090313403533000_9.3.e003281.15","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e31819e67b1"},{"issue":"6 Pt 1","key":"2025090313403533000_9.3.e003281.16","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0761-8425(04)71582-X","article-title":"Opportunistic infections and Sarcoidosis","volume":"21","author":"Girard","year":"2004","journal-title":"Rev Mal Respir"},{"key":"2025090313403533000_9.3.e003281.17","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2217\/fmb-2020-0318","article-title":"Autoimmune diseases in HIV-negative cryptococcal meningitis","volume":"16","author":"Liu","year":"2021","journal-title":"Future Microbiol"},{"key":"2025090313403533000_9.3.e003281.18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/0961203318817118","article-title":"Invasive fungal disease in patients with systemic lupus erythematosus from Southern China: a retrospective study","volume":"28","author":"Lao","year":"2019","journal-title":"Lupus"},{"key":"2025090313403533000_9.3.e003281.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2014.06.001"},{"key":"2025090313403533000_9.3.e003281.20","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jbspin.2014.01.002","article-title":"Mucormycosis in systemic autoimmune diseases","volume":"81","author":"Royer","year":"2014","journal-title":"Joint Bone Spine"},{"key":"2025090313403533000_9.3.e003281.21","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223335"},{"key":"2025090313403533000_9.3.e003281.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2008-740ST"},{"issue":"Suppl 2","key":"2025090313403533000_9.3.e003281.23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s13023-020-01621-3","article-title":"French recommendations for the management of systemic necrotizing Vasculitides (Polyarteritis Nodosa and ANCA-associated Vasculitides)","volume":"15","author":"Terrier","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"2025090313403533000_9.3.e003281.24","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00920-22","article-title":"Active surveillance program to increase awareness on invasive fungal diseases: the French RESSIF network (2012 to 2018)","volume":"13","author":"Bretagne","year":"2022","journal-title":"mBio"},{"key":"2025090313403533000_9.3.e003281.25","doi-asserted-by":"publisher","DOI":"10.1086\/588660"},{"key":"2025090313403533000_9.3.e003281.26","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for research and treatment of cancer and the Mycoses study group education and research consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2025090313403533000_9.3.e003281.27","unstructured":"World Bank open data. World Bank Open Data. Available: https:\/\/data.worldbank.org [Accessed 19 Jul 2023]."},{"key":"2025090313403533000_9.3.e003281.28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1315399"},{"key":"2025090313403533000_9.3.e003281.29","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2009.225"},{"key":"2025090313403533000_9.3.e003281.30","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.072967"},{"key":"2025090313403533000_9.3.e003281.31","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080791"},{"key":"2025090313403533000_9.3.e003281.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.034"},{"key":"2025090313403533000_9.3.e003281.33","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.029207"},{"key":"2025090313403533000_9.3.e003281.34","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2022.152154","article-title":"Is there a role for Pneumocystis Jiroveci pneumonia prophylaxis in giant cell arteritis or Polymyalgia Rheumatica?","volume":"58","author":"Anumolu","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2025090313403533000_9.3.e003281.35","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/RHU.0000000000000731","article-title":"Risk factors for Pneumocystis Jirovecii pneumonia in patients with rheumatoid arthritis and a prophylactic indication of Trimethoprim\/Sulfamethoxazole","volume":"24","author":"Yukawa","year":"2018","journal-title":"J Clin Rheumatol"},{"key":"2025090313403533000_9.3.e003281.36","doi-asserted-by":"publisher","DOI":"10.1007\/s10156-004-0368-5"},{"key":"2025090313403533000_9.3.e003281.37","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/rheumatology\/keab647","article-title":"Prophylaxis against Pneumocystis pneumonia in rheumatoid arthritis patients treated with B\/tsDMARDs: insights from 3787 cases in the FIRST Registry","volume":"61","author":"Sonomoto","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025090313403533000_9.3.e003281.38","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-012-0615-z"},{"key":"2025090313403533000_9.3.e003281.39","first-page":"1186","article-title":"Risk factors for Pneumocystis carinii pneumonia in patients with polymyositis\/dermatomyositis or systemic lupus erythematosus","volume":"23","author":"Kadoya","year":"1996","journal-title":"J Rheumatol"},{"key":"2025090313403533000_9.3.e003281.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.09.009"},{"key":"2025090313403533000_9.3.e003281.41","first-page":"490","article-title":"Guidelines for prophylaxis of Pneumocystis pneumonia cannot rely solely on Cd4-cell count in autoimmune and inflammatory diseases","volume":"36","author":"Baulier","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"2025090313403533000_9.3.e003281.42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jbspin.2009.03.013","article-title":"Low and stable prevalence of rheumatoid arthritis in northern France","volume":"76","author":"Biver","year":"2009","journal-title":"Joint Bone Spine"},{"key":"2025090313403533000_9.3.e003281.43","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.090153"},{"key":"2025090313403533000_9.3.e003281.44","doi-asserted-by":"crossref","DOI":"10.3899\/jrheum.100858","article-title":"Methotrexate and Trimethoprim-Sulfamethoxazole for Pneumocystis pneumonia prophylaxis","volume":"38","author":"Yamazaki","year":"2011","journal-title":"J Rheumatol"},{"key":"2025090313403533000_9.3.e003281.45","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1007\/s10067-018-4005-6","article-title":"Safety of the concomitant use of methotrexate and a prophylactic dose of Trimethoprim-Sulfamethoxazole","volume":"37","author":"Kwon","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2025090313403533000_9.3.e003281.46","doi-asserted-by":"publisher","DOI":"10.1007\/s10165-007-0626-3"},{"key":"2025090313403533000_9.3.e003281.47","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2012.02.001"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2023-003281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:40:49Z","timestamp":1756932049000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2023-003281"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,8,9]]},"published-print":{"date-parts":[[2023,8]]}},"alternative-id":["10.1136\/rmdopen-2023-003281"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2023-003281","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]}}}